ArticleApplied health economics and health policy2017

Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.

Andrew J Leidner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.